Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Nov 30, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PTC | PTC INC | NASDAQ | Software - Application | A | $20.95B | $175.43 | 1.14% | $1.13B | 28.67x | 0.73 | United States | 52 |
| SGHC | SUPER GROUP (SGHC) LTD | NYSE | Gambling | A | $5.48B | $10.83 | -0.91% | N/A | 21.75x | 0.60 | Guernsey | 35 |
| CALX | CALIX INC | NYSE | Software - Application | A | $3.66B | $55.27 | -0.95% | $10.21M | -552.70x | 0.19 | United States | 31 |
| FOLD | AMICUS THERAPEUTICS INC | NASDAQ | Biotechnology | A | $3.06B | $9.93 | -0.90% | $59.28M | -248.25x | 2.77 | United States | 23 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $2.61B | $45.59 | -1.45% | $64.66M | -138.15x | 0.35 | United States | 28 |
| SPNT | SIRIUSPOINT LTD | NYSE | Insurance - Reinsurance | A | $2.43B | $20.80 | -0.62% | $339.10M | 12.53x | 4.64 | Bermuda | 30 |
| EXTR | EXTREME NETWORKS INC | NASDAQ | Communication Equipment | A | $2.34B | $17.50 | 0.11% | $65.83M | 250.00x | 15.82 | United States | 34 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.30B | $177.75 | 0.71% | $301.16M | 10.30x | 1.82 | United States | 50 |
| PGY | PAGAYA TECHNOLOGIES LTD | NASDAQ | Software - Infrastructure | A | $2.06B | $24.95 | 3.79% | -$155.79M | -9.11x | 2.03 | Israel | 21 |
| BLBD | BLUE BIRD CORP | NASDAQ | Auto Manufacturers | A | $1.66B | $52.22 | -0.99% | $194.43M | 13.02x | 1.45 | United States | 46 |
| ANAB | ANAPTYSBIO INC | NASDAQ | Biotechnology | A | $1.15B | $41.65 | -1.21% | -$82.14M | -15.20x | -13.00 | United States | 15 |
| CRTO | CRITEO SA | NASDAQ | Advertising Agencies | A | $1.04B | $19.88 | 0.96% | $219.28M | 6.37x | 0.79 | France | 51 |
| TBPH | THERAVANCE BIOPHARMA INC | NASDAQ | Biotechnology | A | $1.03B | $20.30 | 1.70% | $55.37M | 35.00x | 0.79 | Cayman Islands | 37 |
| NUTX | NUTEX HEALTH INC | NASDAQ | Health Information Services | A | $814.05M | $115.11 | 2.05% | $227.40M | 5.43x | 1.66 | United States | 48 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $657.40M | $5.18 | -4.43% | $18.04M | -43.17x | 0.49 | United States | 23 |
| BWMN | BOWMAN CONSULTING GROUP LTD | NASDAQ | Engineering & Construction | A | $628.56M | $36.18 | 0.36% | $38.00M | 36.92x | 0.95 | United States | 53 |
| VREX | VAREX IMAGING CORP | NASDAQ | Medical Devices | A | $482.47M | $11.57 | 0.00% | -$1.00M | -6.81x | 1.31 | United States | 24 |
| OPRX | OPTIMIZERX CORP | NASDAQ | Health Information Services | A | $284.64M | $15.27 | -0.72% | $11.65M | N/A | 0.39 | United States | 26 |
| EGHT | 8X8 INC | NASDAQ | Software - Application | A | $268.96M | $1.94 | 0.00% | $51.06M | -48.50x | 4.04 | United States | 16 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $223.28M | $26.77 | 0.94% | $12.05M | 27.60x | 0.20 | United States | 54 |
| CXDO | CREXENDO INC | NASDAQ | Telecom Services | A | $214.50M | $6.98 | 1.75% | $7.94M | 46.53x | 0.24 | United States | 42 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $188.72M | $9.28 | 0.32% | $24.16M | 35.69x | 0.78 | United States | 45 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.